113 related articles for article (PubMed ID: 347641)
21. Characterization of surface antigens of transplantable melanomas in hamster on the basis of the macrophage migration inhibition test.
Kozłowska K; Zurawska-Czupa B; Kostulak A
Arch Immunol Ther Exp (Warsz); 1981; 29(1):137-42. PubMed ID: 7283676
[TBL] [Abstract][Full Text] [Related]
22. The NK function elucidated with respect to effector cells, target cells and other immunological in vitro tests.
Kristensen E
Tokai J Exp Clin Med; 1983 Dec; 8(5-6):449-53. PubMed ID: 6681340
[TBL] [Abstract][Full Text] [Related]
23. [Modification of a micromethod for determining leukocyte migration inhibition and its significance in oncological patients].
Kochetkova VA
Lab Delo; 1980; (12):744-6. PubMed ID: 6163894
[No Abstract] [Full Text] [Related]
24. [Cellular immunity in melanomalignome (author's transl)].
Fritz J; Grond K; Tilz GP
Arch Dermatol Res (1975); 1976 Apr; 255(2):203-9. PubMed ID: 1275554
[TBL] [Abstract][Full Text] [Related]
25. [Current developments concerning malignant skin melanoma].
Dargent M
Maroc Med; 1972 Oct; 52(561):571-86. PubMed ID: 4667467
[No Abstract] [Full Text] [Related]
26. [Immunological aspects of melanoma].
Sjögren H
Lakartidningen; 1976 Feb; 73(7):528-30. PubMed ID: 1250045
[No Abstract] [Full Text] [Related]
27. Cell-mediated responses in dogs with spontaneous neoplasms. II. Detection by direct leukocyte migration inhibition technique.
Gorman NT; Betton GR
J Natl Cancer Inst; 1978 Oct; 61(4):1095-100. PubMed ID: 279713
[TBL] [Abstract][Full Text] [Related]
28. Immunobiology of human cutaneous melanoma.
Cochran AJ; Wen DR; Stene M; Fairhurst MV; Hoon DS
Prog Clin Biol Res; 1988; 256():597-618. PubMed ID: 3368501
[No Abstract] [Full Text] [Related]
29. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
[TBL] [Abstract][Full Text] [Related]
30. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
[No Abstract] [Full Text] [Related]
31. Human leucocyte migration under agarose: migration inhibition by soluble and tumor antigens with special reference to antimelanoma activity in healthy blacks.
Tautz C; Khuen F; Ax W
Z Immunitatsforsch Exp Klin Immunol; 1974 Jun; 147(2):155-61. PubMed ID: 4283006
[No Abstract] [Full Text] [Related]
32. Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.
Gutterman JU; Mavligit G; Reed R; Richman S; McBride CE; Hersh EM
Semin Oncol; 1975 Jun; 2(2):155-74. PubMed ID: 790574
[No Abstract] [Full Text] [Related]
33. Demonstration of cellular immunity to tumor-specific antigens of malignant melanoma in hamsters by inhibition of macrophage migration.
Henderson WR; Fukuyama K; Epstein WL; Spitler LE
J Invest Dermatol; 1972 Apr; 58(4):229-32. PubMed ID: 5020976
[No Abstract] [Full Text] [Related]
34. [Immunology of malignant melanoma. Current data].
Pavie-Fischer J; Kourilsky FM
Rev Prat; 1975 Nov; 25(51):4027-8, 4031-3. PubMed ID: 1209142
[No Abstract] [Full Text] [Related]
35. Comparison of the antigenicity of melanotic and amelanotic melanoma cells after the release of surface glycoproteins by trypsin.
Kozłowska K; Zurawska-Czupa B; Kostulak A
Arch Immunol Ther Exp (Warsz); 1980; 28(4):641-4. PubMed ID: 7192976
[TBL] [Abstract][Full Text] [Related]
36. [Immunologic diagnosis of malignant neoplasms. I].
Shuster J; Thomson DM; Fuks A; Gold P
Union Med Can; 1980 Jun; 109(6):902-9. PubMed ID: 7008310
[No Abstract] [Full Text] [Related]
37. Inhibition of macrophage migration by choroidal malignant melanoma-associated antigens in patients with unveal melanoma.
Manor RS; Livni E; Joshua H; Ben-Sira I
Invest Ophthalmol Vis Sci; 1978 Jul; 17(7):684-7. PubMed ID: 352988
[TBL] [Abstract][Full Text] [Related]
38. Studies on antigenicity and immunogenicity of transplantable melanoma in hamster by using migration inhibition test.
Kozłowska K; Zurawska-Czupa B; Kostulak A
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):445-7. PubMed ID: 749795
[TBL] [Abstract][Full Text] [Related]
39. Cellular immunity to human tumor-associated antigens. A review.
Herberman RB
Isr J Med Sci; 1973 Mar; 9(3):300-7. PubMed ID: 4575654
[No Abstract] [Full Text] [Related]
40. [Immunologic profile of malignant melanoma as a basis for further treatment].
Hausner P; Bauer J; Vosmík F; Votava V; Pastorová J; Kulhánek V; Stanová M
Cesk Dermatol; 1980 Aug; 55(4):258-63. PubMed ID: 7407963
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
